Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Lidco Group Plc LSE:LID London Ordinary Share GB0030546849 ORD 0.5P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.03p -0.61% 4.85p 7,500 10:09:16
Bid Price Offer Price High Price Low Price Open Price
4.70p 5.00p 4.88p 4.85p 4.88p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 7.32 -2.14 -0.80 11.8

Lidco (LID) Latest News

More Lidco News
Lidco Takeover Rumours

Lidco (LID) Share Charts

1 Year Lidco Chart

1 Year Lidco Chart

1 Month Lidco Chart

1 Month Lidco Chart

Intraday Lidco Chart

Intraday Lidco Chart

Lidco (LID) Discussions and Chat

Lidco (LID) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
09:09:144.767,500357.00O
View all Lidco trades in real-time

Lidco (LID) Top Chat Posts

DateSubject
17/6/2019
09:20
Lidco Daily Update: Lidco Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker LID. The last closing price for Lidco was 4.88p.
Lidco Group Plc has a 4 week average price of 4.85p and a 12 week average price of 3.70p.
The 1 year high share price is 7.88p while the 1 year low share price is currently 3.40p.
There are currently 244,174,908 shares in issue and the average daily traded volume is 38,249 shares. The market capitalisation of Lidco Group Plc is £11,842,483.04.
25/4/2019
07:17
multibagger: LID is a poorly traded / ill liquid stock - which brings on its own volatility good or bad. If you tot up all the "tightly held" (more than 3% threshold as a rough guide) they make up a decent chunk of around 58% equity at last count...so any good news with contract size/revenues attached should cause it to have a share price "mini spike". However, with the current market sentiment in general, mere regulatory clearance or authorisation to sell in new markets may not be enough to lift the share price in the short term. Longer term regulatory clearances are important and these make a big difference, but stock market traders are a hard to please bunch who want profits a week or two after buying shares ! It would be good to hear back from the AGM meeting - but it does not look like anyone from here will be attending.
18/4/2019
08:06
pugugly: PR to boost the share price is irrelevant expensive and a waste of time – PR addressed to the medical professions (surgical, patient care and hospital financial departments) that can generate interest and adoption is essential. Once invested the key criteria are profitable sales growth and a growing pipeline of high quality enquiries (not time-wasting jobsworths trying to show that they are being busy) Once we have grown profitable market share and bottom line the share price will rise – how far will probably depend on the peceived growth potential and/or take- over rumours/actions.
16/4/2019
11:48
multibagger: 10p in 2021 from a share price point of view would be an excellent return for someone who has recently invested (like me this time around). However, this does not change my view on the laissez faire approach to performance related options in LID. Options cause dilution of equity and to the detriment of shareholders if share price performance does not justify them. Matt has been given a lot of options over the years, but this has not translated into share price performance - what we have seen is a steady decline in share price and good or bad, the buck stops with him. I am already a share holder / fractional owner of the LID business (knowing fully well that I can easily take a RNS notifiable stake at short notice), however, I will not do so, as RNS today does not reflect good corporate culture or governance in my view. I am going to see how this pans out, but at this time I am not impressed in the slightest and intuitively a red flag. It feels wrong to me and I heed my intuition. We may have to agree to disagree on this one buywell2 !
16/4/2019
07:45
buywell2: The prices reflect the state of the current depressed LiDCO share price 6p was the price that several Institutions raised 3M to enable HUP to be initiated Hence 6p is picked for 15% of the grant to vest ... this in my view with the share price at 4.5p up from a low of around 3.3p recently thanks to just us few brave souls Plus two or three BOD buying when they were allowed to. LiDCO rising from 4.5p to 10p is very doable granted ... BUT in order to keep what is obviously a sales wise switched on CEO , a new experienced CFO plus several other Key LiDCO BOD and Staff members ... these things happen. Share options at the structured prices going to 10p and/or above to vest will IMO keep all those who receive them fully motivated. This is now key ... if LiDCO can get to 10p without attracting a BID , then a BID after that should come in around 14p ie a 40% premium. I personally am comfortable with those numbers. Now we need an RNS to say the China approval for LiDCO to start selling again has been finally approved. 5.5p should soon follow ie I expect a one penny rise on the news dyor GLA
16/4/2019
07:25
pugugly: The Company is currently in the process of finalising share option grants to key employees over a further 1,025,000 Ordinary shares. Following these grants, the total number of shares under option will be 20,478,376 representing 8.4% of the issued share capital. https://www.investegate.co.uk/lidco-group-plc--lid-/rns/award-of-share-options-director-dealing/201904160700142619W/ A proportion of the Options may vest and be exercised at 0.5 pence per Ordinary Share anytime between 9 April 2022 and 9 April 2025 if the average share price in the three months ending 9 April 2022 (the "Average Share Price") equals or exceeds 6.00p. At an Average Share Price of 6.00p, 15% of the Options become exercisable, for all of the Options to vest the Average Share Price must equal or exceed 10.00p, and a straight line sliding scale applies to determine the amount vesting if the Average Share Price is between 6.00p and 10.00p. For an £11 million market cap coy current share price 4.5/4.6 I suspect thosse who bought in th elast 4 months would be happy if targets met but long term holders will be disappointed but many who bought 5 years ago may already have sold out.
12/3/2019
17:23
buywell2: Nope I think not LIDCO is on the rise from a very low base after being hammered by BIG selling from City Financial who as far as I can tell/research have sold whatever remained of their original 5,700,000 shares in the company since the start of the year. They never had to issue an RNS because they never held 3% in LIDCO from the start See the volumes add em up since the start of the New Year and you get circa 11m shares traded , ie 5,500,000 sells and 5,500,000 buys. The last savage forced sell off by City Financial ended only a week ago The 10ma has today been breached to the upside and just a trickle of bottom picking fishers have come back in to put their toes in the water. The 25ma is the next target But even at the 3.9p share price that todays buyers were prepared to buy Edwards Lifesciences would IMO have to pay 8p MINIMUM to acquire LIDCO There are others that may well step into the fray if and when Edwards Lifesciences does make a move buywell will make a prediction : I believe the low is now in the chart of LIDCO At the current market cap LIDCO is a sitting duck for being bagged The longer any predator sits still twisting their thumbs watching their market share drop , the higher the market cap of LIDCO gets. Any more positive news flow is going to bring back investors that were previous buyers of LIDCO over a year or so ago but sold out when the string of bad news RNS's started. TIMING is EVERYTHING in the buying and selling of shares but IMO the BEST outcomes in small cap stocks trading on AIM that have GOOD IP, zero debt, a strategic plan in place , the cash to see it through , and a CEO, BoD, Management and Staff to implement it. WAITING till such a company is acquired for CASH by a larger predator is the best way to operate BUT it takes longer (years), but in most cases buywell believes it makes the most sense. Hence I put 10p on LID as a buyout price I expect this bid will get made within 12 months I expect LIDCO will then be trading at between 6p and 7p dyor GLA
07/3/2019
03:10
buywell2: To explain the LIDCO High Usage Plan (HUP) a little clearer I have added this link into the header hTtps://www.youtube.com/watch?v=fkKoU9o1en4 Press the 'resize' button on the right by the video picture to view it better I have also added a link to another Healthcare AIM company I like that has recently made a deal in the Robotic Laparoscopic Surgery market to enter the NHS shortly called Surgical Innovations (SUN) Like LIDCO it has zero debt , it has cash , and just has had a new CEO & COO appointed The share price there is also near a recent 2 year low but again like LIDCO things are looking up. If interested check out https://uk.advfn.com/cmn/fbb/thread.php3?id=35323108 The Dexter robotic deal could be transformational IMO hence I have done a longish explanation of what it is all about, and the size of the UK NHS market. Surgical Innovations have also gone for a DISRUPTIVE offering to the NHS just like LIDCO is doing I like them both dyor GLA.
04/3/2019
03:09
buywell2: May 16th 2019 ----- LiDCO has made a GOOD start to the year with Q1 revenues 38% AHEAD - US revenues 69% AHEAD of Q1 last year and ABOVE the Board's expectations. --------------------------------------------------------------------------------------- ................. LiDCO CEO MATT SASSONE INTERVIEW 25th APRIL 2019 .................... --------------------------------------------------------------------------------------- Lidco's transformation in the last couple of years has turned the company into a real David and Goliath story. Listen to our interview with chief executive Matt Sassone here hTTps://www.investorschampion.com/channel/podcasts/more-than-money-lidco buywell notes from above: remember LiDCO = David .... Edwards Lifesciences = Goliath 1) Matt Sassone says sales into China should commence in the 2nd half of this year 2) He also says regarding the LiDCO High Usage Program (HUP) offerings in the USA and elsewhere that payback after placing the LiDCO Hemodynamic Monitors in such a deal is after 3 MONTHS 3) Also listen to his explanation of why Edwards can't or won't try to replicate LiDCO HUP 4) Also listen to how LiDCO pinched Edwards LARGEST USA Hospital from them to take LiDCO HUP The above is a must listen IF anyone is invested OR thinking of investing in LiDCO IMO !FOLLOWFEED About LiDCO Group Plc: what they do LiDCO is a supplier of non-invasive and minimally invasive hemodynamic equipment to hospitals used to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimisation protocols for high risk patients in both critical care units and in the operating theatre. Increasingly clinical studies are showing that the optimisation of patients' hemodynamic status in high risk patients produces better outcomes and reduced hospital stay. LiDCO's computer-based technology, originally developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery. About the CEO Matthew Sassone took over in 2015 and has since developed a new Lidco strategy for growth. He has previously held positions at Smiths Group PLC's Smiths Medical arm, and his last position before becoming the Lidco CEO was chief marketing officer of Maquet, a division of Getinge Group. . Maquet/Getinge are one of Lidco's main competitors, Matt Sassone knows all about them, handy don't you think? About the Lidco sales push into the USA Lidco has introduced a new disruptive concept designed by Matt Sassone ,as their backbone to win sales in the USA . They call it a High Usage Plan (HUP) and it ties into the new Software as a Service (SaaS) package which they offer hospitals taking up the HUP offering and included a newly designed monitor; HUP was launched July 2017 In Jan 2017 Matt Sassone appointed Shane Doorish as the Lidco head of North America Shane Doorish Doorish brought with him 19 years of experience in the healthcare sector having originally trained as a critical care nurse, then 12 years with Edwards Lifesciences, a major provider of hemodynamic monitoring, where Doorish held a number of sales and marketing positions. His last role with Edwards Lifesciences being the Managing Director of Canada. Edwards Lifesciences is Lidco's biggest competitor, Shane Doorish knows all about them, handy that don't you think ? On Dec 7, 2016 - Matt Sassone was pleased to announce that it had raised £3.0 million at 6p a share which was going to be used to employ a new sales force based in the USA to implement the HUP & SaaS strategic and highly disruptive plan plus the new monitor development. Shane Doorish interviewed and picked a USA sales team and arranged their training on the Lidco equipment they would be offering to targeted Main Hospitals in the USA. In the 6 months from the initial launch of the Lidco HUP 6 Main USA hospitals had signed 3 year HUP contracts with Lidco , including 4 out of the USA Top 20 List of Hospitals , and the number 1 USA listed USA Hospital for cancer treatment. A pipeline of targeted USA Hospital sales enquiries was created and over the next 12 months that followed another 13 Major USA Hospitals have switched their Hemodynamic Monitoring requirements to Lidco. Who are now signing up an average of 1 new USA Hospital each month. The bigger NHS existing clients did not want to be left out , so 4 big NHS Trusts have also now changed over to 3 year HUP contracts. More are expected to do so and other HUP contracts have been signed in Europe. ............. So why is the Lidco share price so cheap ? .............. IMO because the market has at present IMO got it wrong about Lidco, doesn't happen very often but when it does it presents a buying opportunity. hTtp://www.lidco.com/ Building a new LiDCO website | Case Study Posted on August 10, 2017 By John Gregory hTtps://www.opencityinc.com/building-a-new-lidco-website-case-study/#.XOEo6MhKjIV Shane Doorish gets mentioned and was I'm sure instrumental in it happening. Looks like he did a great job with it via Opencity as the USA HUP orders have flown in ever since its creation If you have not seen it , its worth a look htTps://www.lidco.us/ Click this for buywell next 12 month forecast for LIDCO https://uk.advfn.com/cmn/fbb/thread.php3?id=43998569&from=51 dyor PS If you like this thread and a stock that is also in the same sector , and a stock where IMO the timing is also right to invest. Surgical Innovations is also a Healthcare company about to offer a brand new unique and cost effective DISRUPTIVE deal to the NHS to allow them to uptake Robotic Laparoscopic Surgery across a very large number of operations that the NHS have highlighted themselves for this type of surgery. Look at: https://uk.advfn.com/cmn/fbb/thread.php3?id=35323108 A LIDCO VIDEO EXPLAINING THE HIGH USAGE PLAN (HUP) as talked about in the header above !YOUTUBEVIDEO:fkKoU9o1en4:!
07/7/2017
18:12
willib2: Doglover2003, Mmmmmm Do you remember making this post. doglover2003 - 02 Aug 2016 - 08:31:29 - 8280 of 8884 When will DEMG overtake LID share price?
23/1/2015
13:33
arf dysg: Well, well, well. A well is a deep hole, into which the LID share price has dropped. Well, well, well, look at that. The LID share price has dropped. It is going down at a rate of knots. One must keep an open mind about future trends in the Lid to Deltex price ratio.
Lidco share price data is direct from the London Stock Exchange
Your Recent History
LSE
LID
Lidco
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190617 10:40:58